Literature DB >> 27623515

The Author's Reply: inappropriate adrenoreceptor blockade prior to pheochromocytoma removal - 'A timely reappraisal'.

Henrique V Luiz1,2, Run Yu3, Katherine Wolf1, Ning Miao4, Andrew Mannes4, Karel Pacak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27623515      PMCID： PMC5118150          DOI： 10.1111/cen.13234

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  14 in total

1.  Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.

Authors:  Thanh-Truc Huynh; Karel Pacak; Frederieke M Brouwers; Mones S Abu-Asab; Robert A Worrell; Macclellan M Walther; Abdel G Elkahloun; David S Goldstein; Susannah Cleary; Graeme Eisenhofer
Journal:  Eur J Endocrinol       Date:  2005-10       Impact factor: 6.664

2.  Inappropriate adrenoreceptor blockade prior to phaeochromocytoma removal is perhaps a 'timely reappraisal'?

Authors:  Claude Lentschener; Sebastien Gaujoux; Christophe Baillard; Bertrand Dousset
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-15       Impact factor: 3.478

3.  Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.

Authors:  Alessandra Giavarini; Antoine Chedid; Guillaume Bobrie; Pierre-François Plouin; Albert Hagège; Laurence Amar
Journal:  Heart       Date:  2013-07-09       Impact factor: 5.994

4.  Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.

Authors:  G Eisenhofer; J W Lenders; W M Linehan; M M Walther; D S Goldstein; H R Keiser
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

5.  Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study.

Authors:  Gaurav Agarwal; Dhalapathy Sadacharan; Aditya Kapoor; Aditya Batra; Preeti Dabadghao; Gyan Chand; Anjali Mishra; Amit Agarwal; Ashok K Verma; Saroj K Mishra
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

6.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

Review 7.  Preoperative management of the pheochromocytoma patient.

Authors:  Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-11       Impact factor: 5.958

8.  Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors.

Authors:  Run Yu; Lena Furmark; Christopher Wong
Journal:  Endocr Pract       Date:  2009 Jan-Feb       Impact factor: 3.443

9.  Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Authors:  Henrique Vara Luiz; Mary Jane Tanchee; Maria G Pavlatou; Run Yu; Joan Nambuba; Katherine Wolf; Tamara Prodanov; Robert Wesley; Karen Adams; Tito Fojo; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-15       Impact factor: 3.478

10.  [Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery].

Authors:  J Schüttler; P Westhofen; U Kania; H Ihmsen; S Kammerecker; A Hirner
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  1995-10       Impact factor: 0.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.